Richard Mulligan

Insider Reports History

Entity
Individual
Location
C/O Icahn Capital Lp, 767 Fifth Avenue, Suite 4700, New York, NY
Signature
/s/ Julie Shah, Attorney-in-Fact for Richard Mulligan
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Richard Mulligan:

Stock Role Class Num Shares Value Price $ Report Date Ownership
BIOGEN INC. Director Common Stock 15.1K $3.74M $248.00 Jun 15, 2022 Direct
Bausch Health Companies Inc. Director Common Shares, No Par Value 101K $1.07M $10.61 May 17, 2024 Direct
Sana Biotechnology, Inc. Director Stock Option (Right to Buy) 65K Jun 6, 2024 Direct

Insider Reports Filed by Richard Mulligan

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SANA Sana Biotechnology, Inc. Jun 6, 2024 1 $0 4/A Jul 15, 2024 Director
SANA Sana Biotechnology, Inc. Jun 6, 2024 1 $0 4 Jun 7, 2024 Director
BHC Bausch Health Companies Inc. May 17, 2024 0 $0 4/A May 21, 2024 Director
BHC Bausch Health Companies Inc. May 17, 2024 1 $0 4/A May 20, 2024 Director
BHC Bausch Health Companies Inc. May 19, 2023 1 $0 4 May 19, 2023 Director
SANA Sana Biotechnology, Inc. Mar 2, 2023 1 $0 4 Mar 3, 2023 Head of SanaX, Director
BHC Bausch Health Companies Inc. Jun 24, 2022 1 $0 4 Jun 28, 2022 Director
BIIB BIOGEN INC. Jun 15, 2022 1 $0 4 Jun 17, 2022 Director
BHC Bausch Health Companies Inc. May 13, 2022 1 $0 4 May 17, 2022 Director
BHC Bausch Health Companies Inc. May 10, 2022 0 $0 3 May 12, 2022 Director
SANA Sana Biotechnology, Inc. Mar 3, 2022 1 $0 4 Mar 8, 2022 Head of SanaX, Director
BIIB BIOGEN INC. Jul 1, 2021 1 $0 4 Jul 2, 2021 Director